Entrada Therapeutics Reports First Quarter 2025 Financial Results

Go back to Entrada Therapeutics Reports First Quarter 2025 Financial Results
(NASDAQ: TRDA) Delayed: 5.55 -0.06 (1.07%)
Previous Close $5.61    52 Week High $ 
Open $5.52    52 Week Low $ 
Day High $5.57    P/E N/A 
Day Low $5.25    EPS $ 
Volume 106,378